Antonia Peter

Ms. Antonia Peter

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2025 in Cells
Verified
Journal Article
Open access
PDF file
APAntonia Peter
Antonia Peter
MVMorgane Vermeulen
Morgane Vermeulen
MDMats Van Delen
Mats Van Delen
ADAmber Dams
Amber Dams
SPStefanie Peeters
Stefanie Peeters
NCNathalie Cools
Nathalie Cools
Dendritic cells (DCs) are critical regulators of immune homeostasis, balancing tolerance and immunity through antigen presentation and T cell modulation. While the influence of hypoxia (<2% O2) on DC function in pathological settings is well-documented, the impact of physiological O2 levels remains underexplored. This study investigates the role of physioxia (4% O2) in programming mature DCs toward a tolerogenic phenotype compared to atmospheric conditions (21% O2) typically present in in vitro assays. DC cultures generated under 4% O2 exhibited a reduced monocyte-to-DC transformation rate, increased lactate production, a semi-mature surface marker profile, and increased surface expression of the tolerance-associated marker ILT4. T cell priming was altered only when atmospheric DCs were co-cultured under physioxia, suggesting an O2-dependent threshold for immunostimulatory capacity. These findings highlight the complexity of O2-dependent mechanisms in DC-T cell interactions, revealing a delicate balance between tolerance and immunogenicity. Our results underscore the need for physiologically relevant O2 conditions in DC research to better reflect in vivo behavior and inform immunotherapy design. Overall, this study advances understanding of how microenvironmental cues shape DC biology, with implications for immune tolerance, autoimmunity, and cancer immunotherapy.

4 December 2024 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
APAntonia Peter
Antonia Peter
ZBZwi N. Berneman
Zwi N. Berneman
NCNathalie Cools
Nathalie Cools
Dendritic cells (DCs) are specialized antigen-presenting cells crucial for initiating and regulating adaptive immune responses, making them promising candidates for therapeutic interventions in various immune-mediated diseases. Increasing evidence suggests that the microenvironment in which cells are cultured, as well as the milieu in which they perform their functions, significantly impact their immunomodulatory properties. Among these environmental factors, the role of oxygen in DC biology and its significance for both their in vitro generation and in vivo therapeutic application require investigation. Unlike the atmospheric oxygen level of 21 % commonly used in in vitro assays, physiological oxygen levels are much lower (3-9 %), and hypoxia (<1.3 %) is a prevalent condition of both healthy tissues and disease states. This mismatch between laboratory and physiological conditions underscores the critical need to culture and evaluate therapeutic cells under physiologically relevant oxygen levels to improve their translational relevance and clinical outcomes. This review explores the characteristic hallmarks of human DCs that are influenced by oxygen-dependent pathways, including metabolism, phenotype, cytokine secretion, and migration. Furthermore, we discuss the potential of manipulating oxygen levels to refine the generation and functionality of DCs for therapeutic purposes.

22 January 2026 in Experimental Hematology & Oncology
Verified
Journal Article
Open access
APAntonia Peter
Antonia Peter
TTTamara Traitteur
Tamara Traitteur
SCSara Calitz
Sara Calitz
MVMorgane Vermeulen
Morgane Vermeulen
MDMats Van Delen
Mats Van Delen
NCNathalie Cools
Nathalie Cools
Tolerogenic dendritic cells (tolDCs) hold promise for treating autoimmune diseases, potentially restoring antigenspecific immune tolerance without systemic immunosuppression. However, their behavior in vivo remains incompletely understood, particularly in response to microenvironmental factors such as oxygen (O 2) tension. While tolDCs are typically generated and functionally validated under atmospheric O 2 (21%), physiological O 2 levels (physioxia) in human tissues are considerably lower (3-9%). The primary aim of this study was to assess whether tolDCs manufactured under atmospheric O 2 conditions retain their function under physioxia at 4% O 2 , mimicking tissue environments encountered upon clinical administration. To contextualize these findings, we also evaluated the effect of physioxia during in vitro generation and investigated underlying metabolic adaptations. We demonstrate that tolDCs generated under atmospheric O 2 conditions remain functionally effective in physioxic environments, preserving migratory capacity and the ability to induce T cell hyporesponsiveness. Furthermore, physioxia during tolDC generation impaired monocyte-to-tolDC differentiation efficiency, whereas hallmark tolerogenic features, including low expression of CD80, CD83, and CD86, remained intact. Metabolic profiling revealed a distinct shift under physioxia, with reduced mitochondrial reserve capacity and increased glycolytic activity. This suggests metabolic plasticity without loss of function across O 2 environments. Our findings indicate that physiological O 2 shapes tolDC differentiation and metabolism but does not compromise immunoregulatory traits. Importantly, tolDCs generated under atmospheric O 2 remained functionally competent in physioxic environments, reinforcing their suitability for therapeutic use. By modeling in vivo-relevant O 2 levels, this study provides new insights into how microenvironmental O 2 may shape tolDC behavior following clinical administration.

2 July 2025
Verified
Thesis
Closed access
APAntonia Peter
Antonia Peter
The immune system must strike a delicate balance between defending the host against pathogens and maintaining tolerance to self. Dendritic cells (DCs), as professional antigen-presenting cells, are pivotal in orchestrating this balance. Among them, tolerogenic DCs (tolDCs) have emerged as promising candidates for restoring immune tolerance in autoimmune diseases and supporting graft acceptance in transplantation. Unlike general immunosuppressants, tolDCs enable antigen-specific immune modulation, offering precision without global immunosuppression. This thesis investigates how oxygen (O₂)-dependent metabolic programming influences DC biology, with the aim of optimizing tolDC generation for therapeutic use. The central hypothesis posits that O₂ tension—a key physiological cue—can direct DC metabolism and thus influence their immunological identity. The project was motivated by a practical bottleneck: lower differentiation efficiency of GMP-grade tolDCs compared to conventional DCs (cDCs), possibly linked to altered metabolic demands. Preliminary data indicated higher O₂ consumption in tolDCs, prompting an in-depth investigation into the effects of physiological O2 levels (physioxia; 4% O₂), which better reflects in vivo tissue conditions than standard atmospheric O₂ (21%). A literature review highlights that most in vitro DC studies rely on non-physiological oxygen levels, potentially skewing results. Low O₂ tension is shown to modulate DC metabolism, phenotype, cytokine profiles, and T cell interactions, advocating for the adoption of physioxic culture conditions. Experimental work demonstrated that cDCs cultured under physioxia acquired a more tolerogenic profile with reduced T cell stimulatory capacity, without compromising mitochondrial integrity. In contrast, tolDCs generated under physioxia maintained key tolerogenic features and displayed a glycolytic metabolic shift, supporting their robustness across O₂ conditions and affirming the robustness of current GMP protocols. To streamline tolDC assessment, the release of apoptotic bodies (ApoBDs) was evaluated as a surrogate marker of tolerogenic potential. TolDCs released significantly more ApoBDs than cDCs in responsive donor cultures, although correlations with functional potency did not reach significance. Nonetheless, ApoBDs remain a promising candidate for early-phase product screening. Together, these findings highlight the critical role of microenvironmental O₂ tension in modulating DC fate and function. They also offer practical insights into optimizing tolDC manufacturing and quality control, paving the way toward more effective, antigen-specific immunotherapies.